Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-γ expression involved in the development of Th1 insulitis in NOD mice

Journal of Autoimmunity

Volumn 10, Issue 3, 1997, Pages 251-256

  Rothe, Helga ^a   Hibino, Tutsomu ^a   Itoh, Yasuhiro ^a   Kolb, Hubert ^a   Martin, Stephan ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

IGIF; Insulitis; NOD mice; Th1 Th2 balance

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; AUTOIMMUNITY; CONFERENCE PAPER; HAPLOTYPE; IMMUNOHISTOCHEMISTRY; INSULITIS; KUPFFER CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0031171235     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0135     Document Type: Conference Paper

References (20)

1. Signore A., Proccacini E., Toscano A.M., Ferretti E., Williams A.J., Beales E.P., Cugini P., Pozzilli P. Histological study of pancreatic beta cell loss in relation to the insulitis process in the non-obese diabetic mouse. Histochemistry. 101:1995;263-269.
2. Bowman M.A., Leiter E.H., Atkinson M.A. Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease. Immunol. Today. 15:1994;115-120.
3. Yasunami R., Bach J.F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18:1988;481-484.
4. Shehedeh N.N., LaRosa F., Lafferty K.J. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:1993;291-300.
5. Rothe H., Faust A., Schade U., Kleemann R., Bosse G., Hibino T., Martin S., Kolb H. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not interleukin-4. Diabetologia. 37:1994;1154-1158.
6. Katz J.D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science. 268:1995;1185-1188.
7. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory function in the generation of T-helper cells type I and cytotoxic lymphocytes. Blood. 48:1994;4008-4027.
8. Rothe H., Burkart V., Faust A., Kolb H. Interleukin-12 gene expression is associated with development of diabetes mellitus in non-obese diabetic mice. Diabetologia. 39:1996;119-122.
9. Trembleau S., Penna G., Bosi E., Mortara A., Gately M.K., Adorini L. Interleukin-12 administration induces T helper type I cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:1995;817-821.
10. Okamura H., Tsutsui H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K, Fukuda S., Kurimoto M. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature. 378:1994;88-91.
11. Rothe H., Jenkins N.A., Copeland N.G., Kolb H. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J. Clin. Invest. 99:1997;469-474.
12. Kolb H., Wötz-Pagenstert U., Kleemann R., Rothe H., Rowsell P., Scott F.W. Cytokine gene expression in BB rat pancreas: natural course and impact of bacterial vaccines. Diabetologia. 39:1996;1448-1454.
13. Radons J., Burkart V., Kolb H. MHC class II dependent abnormal reactivity towards bacterial toxins in immune cells of nonobese diabetic mice. Diabetes. 45:1997;379-385.
14. Rabinovitch A., Sorensen O., Suarez-Pinzon W.L., Power R.F., Rajotte R.V., Bleackley R.C. Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice: interleukin 2 and interferon gamma mRNA expression correlate with graft rejection and interleukin 10 with graft survival. Diabetologia. 37:1994;833-837.
15. Murray J.S., Pfeiffer C., Madri J., Bottomly K. Major histocompatibility complex (MHC) control of CD4+ T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype. Eur. J. Immunol. 22:1992;559-565.
16. Schmitz J., Assenmacher M., Radbruch A. Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells. J. Immunol. 23:1993;191-199.
17. Rossibergmann B., Muller I., Godinho E.B. Th1 and Th2 T-cell subsets are differentially activated by macrophages and B-cells in murine Leishmaniasis. Infect. Immun. 61:1993;2266-2269.
18. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α J. Exp. Med. 179:1994;1109-1118.
19. Sarukhan A., Bedossa P., Garchon H.J., Bach J.F., Carnaud C. Molecular analysis of TCR junction variability in individual infiltrated islets of non-obese diabetic mice: evidence for the constitution of largely autonomous T cell foci within the same pancreas. Int. Immunol. 7:1995;139-146.
20. McInerney M.F., Flynn J.C., Goldblatt P.J., Najjar S.M., Sherwin R.S., Janeway C.A. Jr. High density insulin receptor-positive lymphocytes from nonobese diabetic transfer insulitis and diabetes. J. Immunol. 157:1996;3716-3726.